These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 16721275)

  • 1. Baseline severity of sepsis in subjects of the prowess and the Kybersept clinical trials on endogenous anticoagulants.
    Wiedermann CJ; Keinecke HO; Jürs M; Opal SM
    Shock; 2006 Jun; 25(6):657-8. PubMed ID: 16721275
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated protein C in severe sepsis--joyful news].
    Møller K; Skinhøj P
    Ugeskr Laeger; 2001 Mar; 163(12):1713. PubMed ID: 11284413
    [No Abstract]   [Full Text] [Related]  

  • 3. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe sepsis with recombinant human activated protein C in a patient with traumatic intracranial hemorrhage.
    Schuster R; Waxman K
    J Trauma; 2007 Aug; 63(2):E34-6. PubMed ID: 17693815
    [No Abstract]   [Full Text] [Related]  

  • 5. Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis.
    Yan SB; Dhainaut JF; Schwarz HP; Ehrlich HJ
    Crit Care Med; 2004 Feb; 32(2):618; author reply 618-9. PubMed ID: 14758203
    [No Abstract]   [Full Text] [Related]  

  • 6. Activated protein C (Xigris) for severe sepsis.
    Med Lett Drugs Ther; 2002 Feb; 44(1124):17-8. PubMed ID: 11856952
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated protein C for the treatment of severe sepsis.
    Houston G; Cuthbertson BH
    Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe sepsis in a premature neonate: protein C replacement therapy.
    De Carolis MP; Polimeni V; Papacci P; Lacerenza S; Romagnoli C
    Turk J Pediatr; 2008; 50(4):405-8. PubMed ID: 19014060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.
    Chawla LS; Seneff MG; Nelson DR; Williams M; Levy H; Kimmel PL; Macias WL
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):22-30. PubMed ID: 17699383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From mice to men: treating sepsis with heparin.
    Zarychanski R
    Crit Care Med; 2011 May; 39(5):1225-6. PubMed ID: 21610590
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sepsis and severe sepsis].
    Kushimoto S
    Rinsho Byori; 2009 May; Suppl 143():84-98. PubMed ID: 20845877
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
    van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
    Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new tool for fighting sepsis.
    Devlin MM
    Nurs Manage; 2004; Suppl():33-5. PubMed ID: 15303508
    [No Abstract]   [Full Text] [Related]  

  • 14. From the bedside back to the bench: the role of preclinical studies in understanding clinical therapies.
    Marshall JC
    Crit Care Med; 2010 Jan; 38(1):329-30. PubMed ID: 20023488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Highlighting the potential of heparin in the treatment of sepsis in view of failure of KyberSept and OPTIMIST projects].
    Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):134-7. PubMed ID: 17376263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effects of early administration of low-dose heparin in patients with severe sepsis].
    Zhang XJ; Ma XC
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1209-11. PubMed ID: 17147870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
    Eid A; Wiedermann CJ; Kinasewitz GT
    Anesth Analg; 2008 Nov; 107(5):1633-8. PubMed ID: 18931224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sepsis therapy -- how effective are the therapy strategies?].
    Brunkhorst F; Reinhart K
    Chirurg; 2008 Sep; 79(9):877-8. PubMed ID: 18942197
    [No Abstract]   [Full Text] [Related]  

  • 19. [Readministration of drotrecogin alpha in a patient with Crohn's disease].
    Cid Conde L; Varela Correa JJ; Padrón Gil C
    Farm Hosp; 2006; 30(3):193-5. PubMed ID: 16999567
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated protein C: controversy and hope in the treatment of sepsis.
    Baillie JK
    Curr Opin Investig Drugs; 2007 Nov; 8(11):933-8. PubMed ID: 17979027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.